Serious adverse outcomes are categorized according to FDA-defined criteria, including: mortality (DE), life-threatening conditions (LT), hospitalization (HO), disability (DS), congenital anomalies (CA), and other medically significant events (OT)
The FDA-approved oral formulation (Rybelsus for diabetes, Wegovy pill for weight loss) has been clinically validated but requires much higher doses than injectable versions
Vial label has no batch number, no fill weight, or no manufacturer identifier
Lower glutathione levels are prevalent with many health conditions and can be depleted through stress, lack of sleep and exposure to toxins
Injection technique matters With compounded tirzepatide from Priority Meds or any provider, you are typically administering the injection yourself